» Articles » PMID: 26625006

Hypermethylation of Genes in Testicular Embryonal Carcinomas

Overview
Journal Br J Cancer
Specialty Oncology
Date 2015 Dec 2
PMID 26625006
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Testicular embryonal carcinoma (EC) is a major subtype of non-seminomatous germ cell tumours in males. Embryonal carcinomas are pluripotent, undifferentiated germ cell tumours believed to originate from primordial germ cells. Epigenetic changes during testicular EC tumorigenesis require better elucidation.

Methods: To identify epigenetic changes during testicular neoplastic transformation, we profiled DNA methylation of six ECs. These samples represent different stages (stage I and stage III) of divergent invasiveness. Non-cancerous testicular tissues were included. Expression of a number of hypermethylated genes were examined by quantitative RT-PCR and immunohistochemistry (IHC).

Results: A total of 1167 tumour-hypermethylated differentially methylated regions (DMRs) were identified across the genome. Among them, 40 genes/ncRNAs were found to have hypermethylated promoters. Quantitative RT-PCR confirmed downregulation of 8 out of 9 of the genes. Among the confirmed genes, five were sex-linked genes, including X-linked genes STAG2, SPANXD/E and MIR1184, and Y-linked genes RBMY1A1/1B/1D and FAM197Y2P. RBMY1A is a testis-specific gene for spermatogenesis. RNF168 and USP13 are potential tumour suppressors. Expression of RBMY1A was lost in EC and seminoma as documented in the Protein Atlas. We confirmed downregulation of USP13 in EC by IHC.

Conclusions: Our genome-wide analysis of testicular EC identified methylation changes in several previously unknown genes. This may provide insight of crosstalk between normal germ cell development and carcinogenesis.

Citing Articles

Gene-vegetarianism interactions in calcium, estimated glomerular filtration rate, and testosterone identified in genome-wide analysis across 30 biomarkers.

Francis M, Westerman K, Manning A, Ye K PLoS Genet. 2024; 20(7):e1011288.

PMID: 38990837 PMC: 11239071. DOI: 10.1371/journal.pgen.1011288.


Recent Advancements in Research on DNA Methylation and Testicular Germ Cell Tumors: Unveiling the Intricate Relationship.

Nicu A, Ionel I, Stoica I, Burlibasa L, Jinga V Biomedicines. 2024; 12(5).

PMID: 38791003 PMC: 11117643. DOI: 10.3390/biomedicines12051041.


Roles of ubiquitin‑specific protease 13 in normal physiology and tumors (Review).

Tao Y, Xu X, Shen R, Miao X, He S Oncol Lett. 2024; 27(2):58.

PMID: 38192665 PMC: 10773187. DOI: 10.3892/ol.2023.14191.


Epigenome-wide development and validation of a prognostic methylation score in intrahepatic cholangiocarcinoma based on machine learning strategies.

Chen X, Dong L, Chen L, Wang Y, Du J, Ma L Hepatobiliary Surg Nutr. 2023; 12(4):478-494.

PMID: 37601000 PMC: 10432305. DOI: 10.21037/hbsn-21-424.


Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis.

von Eyben F, Kristiansen K, Kapp D, Hu R, Preda O, Nogales F Int J Mol Sci. 2023; 24(4).

PMID: 36835562 PMC: 9966837. DOI: 10.3390/ijms24044148.


References
1.
Swerdlow A, Schoemaker M, Higgins C, Wright A, Jacobs P . Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J Natl Cancer Inst. 2005; 97(16):1204-10. DOI: 10.1093/jnci/dji240. View

2.
Kouprina N, Noskov V, Solomon G, Otstot J, Isaacs W, Xu J . Mutational analysis of SPANX genes in families with X-linked prostate cancer. Prostate. 2007; 67(8):820-8. DOI: 10.1002/pros.20561. View

3.
Mirabello L, Kratz C, Savage S, Greene M . Promoter methylation of candidate genes associated with familial testicular cancer. Int J Mol Epidemiol Genet. 2012; 3(3):213-27. PMC: 3459216. View

4.
Daugaard G, Karas V, Sommer P . Inguinal metastases from testicular cancer. BJU Int. 2006; 97(4):724-6. DOI: 10.1111/j.1464-410X.2006.06017.x. View

5.
Almstrup K, Nielsen J, Mlynarska O, JANSEN M, Jorgensen A, Skakkebaek N . Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells. Br J Cancer. 2010; 103(8):1269-76. PMC: 2967056. DOI: 10.1038/sj.bjc.6605880. View